The potential benefit of stem cell therapy after stroke: an update by Banerjee S, Williamson DA, Habib N, Chataway J

Get full text

Adult-onset neurodegeneration with brain iron accumulation and cortical alpha-synuclein and tau pathology: a distinct clinicopathological entity. by Tofaris, G, Revesz, T, Jacques, T, Papacostas, S, Chataway, J

Space re-exploration in hemispatial neglect. by Parton, A, Malhotra, P, Nachev, P, Ames, D, Ball, J, Chataway, J, Husain, M

Decentralised clinical trials in multiple sclerosis research by Garjani, A, Liu, BJ-Y, Allen, CM, Gunzler, DD, Gerry, SW, Planchon, SM, das Nair, R, Chataway, J, Tallantyre, EC, Ontaneda, D, Evangelou, N

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease by Foltynie, T, Gandhi, S, Gonzalez-Robles, C, Zeissler, M-L, Mills, G, Barker, R, Carpenter, J, Schrag, A, Schapira, A, Bandmann, O, Mullin, S, Duffen, J, Tofaris, GK, McFarthing, K, Chataway, J, Parmar, M, Carroll, C

Work in progress: quality of life (QoL) and neurological disease - trajectories of outcome in neurological conditions (TONiC): a study protocol by Gibbons, C, Cousins, R, Pomeroy, I, Ando, H, Al-Chalabi, A, Chataway, J, Constaninescu, C, Ealing, J, Hawkins, C, Morrison, K, Palace, J, Robertson, N, Rog, D, Scolding, N, Sharrack, B, Shaw, P, Talbot, K, Williams, T, Tennant, A, Young, C, Grp, T

Design and rationale of the determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis (DELIVER-MS) t... by Ontaneda, D, Tallantyre, E, Nakamura, K, Planchon, S, Miller, D, Hersh, C, Chaudhry, B, Bale, C, Alvarez, E, Chataway, J, Craner, M, Freeman, L, Frost, N, Goldman, M, Hobart, J, Hunt, D, Hutton, G, Hyland, M, Joseph, F, Lily, O, Moses, H, Nicholas, J, Nicholas, R, Overell, J, Pearson, O, Pomeroy, I, Smith, A, Zabeti, A, Gerry, S, Gunzler, D, Coles, A, LaRocca, N, Gray, E, Cohen, J, Evangelou, N